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Patient Information Form (PIF) 
Patient Initials: J.G.  
 
Patient Age: 23 years old; D.O.B.: 1987 
 
History of Present Illness:  
A female patient presents to the acute psychiatric facility (brought in by husband this morning). 
Her husband reported that she has been tearful and melancholy for the past 4 days. Husband 
reports she has not been sleeping or eating well over the past month and that she seems 
withdrawn and looks physically, mentally, and emotionally “not there.”  
 
Chief complaint:  
“I want to die…”  
 
Past Psychiatric Medical History:  
Bipolar II; Major depressive disorder; generalized anxiety disorder, body dysmorphic disorder 
history, anorexia nervosa and bulimia nervosa  
 
Detailed Medication Use History:  
Medication Used Duration of treatment   Reason Stopped   
Fluvoxamine   8 months (daily dose: 200 mg)  “headaches”  
Fluoxetine   14 month (daily dose: 80 mg)  “lacking effects  
Sertraline   12 months (daily dose: 150 mg)   “never worked”  
Mirtazapine   3 months (daily dose 30 mg)   “I donʼt want wt. gain”  
Diphenhydramine  Off-and-on (used 50mg PRN)   “so fatigued“ 
Caffeine   1 year (daily dose: 600 mg)   “made me manic before”  
Carbamazepine  5 months (daily dose: 1200 mg)   “I was so weak.”   
Lorazepam   1 month (daily dose: 4 mg)   “MD took me off.”   
Buspirone  4 months (daily dose: 30 mg)   “made me agitated”   
Duloxetine   9 months (daily dose: 60 mg)   “couldnʼt sleep”  
Nortriptyline   6 months (daily dose: 40 mg)   “…blurred vision”  
Quetiapine   4 months (daily dose: 200 mg)   “…blurred vision.”  
Ziprasidone   8 months (daily dose: 240 mg)   “chest pain.”   
 
Intolerances:  
Reports not wanting to try “anything I have used in the past” for fear that she has become 
“resistant to it according to what I have read and understood about pharmacology” from “various 
resources.”  
 
Medical Diagnoses   
Seasonal allergies, “pre-diabetes,” current smoker (2PPD), and headaches  
 
Personality disorders  
Meets criteria for borderline personality   
 
Surgical History 
Rhinoplasty (3 times); breast augmentation; liposuction (2 times) 
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Past Stressor History:  
Dismissed from medical school for academic misconduct 4 years ago; has been unable to 
interview for admission at other schools due to embarrassment and guilt.  
 
She reported at the time that she had multiple problems happening in her life including a divorce, 
legal complications and problems with adhering to her medication regimen.  
 
Her last manic episode was during this time and she stated she tried to take her exam without 
adequately preparing because she thought she “could remember everything.” During the exam, 
she got out of her chair and started to cry, asking proctors, her professors, and colleagues for 
answers.  
 
She started to have physical symptoms consistent with severe anxiety and panic disorder. She 
has never had a manic episode of this magnitude again and denies having ever had a panic 
attack like this again.   
 
Childhood/Early Adulthood:  
JG grew up in the suburbs of the Midwest in Indiana, United States. She was oldest of 4 children 
and her parents divorced when she was 14. Significant events described by JG include: being 
molested by a male relative (uncle) at age 13, and being bullied by an older girl in high school for 
2 years. She dropped out of high school at the age of 17, but completed her G.E.D. and attended 
a community college.  
 
Adulthood and Relationships:  
She married during college and everything seemed to be going well as she was accepted to 
medical school. Her husband became more jealous of her experiences and this lead to a divorce, 
but not before she became pregnant by her husband. During her pregnancy they went through a 
bitter divorce and she subsequently miscarried during medical school and took 3 years off from 
school.  
 
Education:  
Bachelorʼs degrees in business and biology  
Certificate in management  
2 semesters of medical school completed  
 
Current Occupation:  
Shift manager at Dunkinʼ Donuts. She started working there years ago and has been in the same 
occupation off-and-on for the better part of a decade. She has always had a place in this 
company when “other plans havenʼt worked out.” 
 
Current Prescription Medications:  
Trazodone; Escitalopram; Valproate Clonazepam; Loratidine; Topiramte, Olanzapine  
 
Current Prescription Medication Specifics:  
Medication   Dose   Indication   Toxicity  
Trazodone   150 mg QHS   Sleep/Sexual ADR  Denies  
Escitalopram   20 mg QAM  Mood / Depression  Sexual ADRs  
Valproate   500 mg TID  Mood / Stability   Denies  
Clonazepam   0.5 mg BID PRN Anxiety   Denies  
Loratidine   Not using   Seasonal allergies  Denies  
Topiramate   200 mg QAM  Mood / Headaches Daytime sleepiness  
Olanzapine   60 mg daily   Mood / Stability   Weight gain 
